K. K. Pharma Solutions

TRODELVY® (sacituzumab govitecan-hziy) is a prescription medicine used to treat adults with:

• triple-negative breast cancer (negative for estrogen and progesterone hormone receptors and HER2) that has spread to other parts of the body (metastatic) or cannot be removed by surgery, and who have received two or more prior treatments, including at least one treatment for metastatic disease.
• hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has spread to other parts of the body or cannot be removed by surgery, and who previously received endocrine therapy and at least two additional treatments for metastatic disease
• bladder cancer and cancers of the urinary tract that have spread or cannot be removed by surgery, and who have received a platinum-containing chemotherapy medicine and also received an immunotherapy medicine. This indication is approved based on medical studies that measured how many patients responded and how long they responded. Continued approval may depend on benefit demonstrated in additional medical studies.

It is not known if TRODELVY is safe and effective in people with moderate or severe liver problems or in children.

Additional Information:

• Delivery Time: within a week

Avastin 100mg Injection is an effective medicine, first-line option when used together with other cancer medicines. It is given as an infusion. That means you get it through a small needle in your vein or through a port, which is a device placed under your skin. The doctor will decide your dose and duration and will check you for signs of an infusion reaction such as high blood pressure and trouble breathing. You keep taking Avastin 100mg Injection as long as your disease is controlled and your side effects are manageable. Your doctor will determine whether you should stop taking it or not. You may be advised to check blood pressure and levels of protein in urine while you are taking this medication.

The most common side effects of this medicine include rectal bleeding, taste change, and headache. Inform your doctor that you are taking this medication before undergoing any surgical procedure, as the drug has ability to lower the ability of wound healing. Other than this, it also enhances your risk of bleeding thus if you notice any unusual bleeding or bleeding consult with your doctor immediately.

• Nosebleeds
• Headache
• High blood pressure
• Inflammation of the nose
• Protein in urine
• Taste change
• Dry skin
• Hemorrhage
• Increased lacrimation
• Back pain
• Exfoliative dermatitis

Jemperli is FDA-approved to treat certain forms of endometrial cancer in adults. It’s used for endometrial cancer that’s:

• advanced (has spread to other places outside the uterus) or recurrent (has come back after past treatment), and
• has certain genetic changes called mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) mutations*Jemperli side effects

  Jemperli can cause mild or serious side effects. The following lists contain some of the key side effects that may occur while taking Jemperli. These lists do not include all possible side effects.

  For more information about the possible side effects of Jemperli, talk with your doctor or pharmacist. They can give you tips on how to manage any side effects that may be concerning or bothersome.

• Dinutuximab is used in combination with other medications to treat neuroblastoma, a rare cancer of the nervous system in children.
• Typically administered after the child shows improvement from previous treatments.
• Dinutuximab may also be used for other purposes not listed in standard medication guides.
• Qarziba is a dinutuximab-based medicine, recognized for its effectiveness in advanced medical treatments.
• Qarziba Dinutuximab 4.5 mg price in India is an important consideration due to its value in providing targeted treatment.
• Qarziba 4.5 mg/ml offers a precise dosage, requiring accurate mg to ml conversion for proper administration.
• The price of dinutuximab in India reflects its specialized nature, typically used in treatments that involve dinutuximab injections.
• The manufacturer of Qarziba has achieved FDA approval, confirming its quality and effectiveness for eligible patients.
• Understanding dosage conversions (e.g., 4.5 mg/ml or 15 mg/ml) is critical for correct administration.
• Factors like availability, price, and specifications (e.g., fiyatı and preço) are key in treatment planning.
• Correct spelling and identification of the drug (e.g., Qarziba, Quarziba, Qaziba, Garziba, or Karziba) are crucial for proper research and sourcing.
• Qarziba represents a beacon of hope for patients, reflecting advancements in medical science.
• The manufacturer of Qarziba plays a pivotal role in ensuring accessibility and improving patient outcomes.Dinutuximab side effects
  • Get emergency medical help if your child has signs of an allergic reaction: hives; difficult breathing; swelling of the face, lips, tongue, or throat.
  • Some side effects may occur during the injection or up to 24 hours afterward. Qarziba 4.5 mg/ml Tell your child’s caregiver if the child seems dizzy or light-headed, or has a skin rash, chest tightness, wheezing, trouble breathing, or swelling in the face.
  • Capillary leak syndrome is a rare but serious side effect. Qarziba 4.5 mg/ml Call your doctor right away if your child has signs of this condition: stuffy or runny nose followed by tiredness, thirst, decreased urination, trouble breathing, and sudden swelling or weight gain.
  • Dinutuximab can damage red blood cells, which may cause irreversible kidney failure. Call Dinutuximab Price your doctor right away if your child has unusual bruising or bleeding, pale skin, confusion, tiredness or irritability, stomach pain, bloody diarrhea, red or pink urine, swelling, rapid weight gain, and little or no urination.

Fetroja® (cefiderocol) is indicated in patients 18 years of age or older for the treatment of complicated urinary tract infections (cUTIs), including pyelonephritis caused by the following susceptible Gram-negative microorganisms: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Enterobacter cloacae complex.

Fetroja is indicated in patients 18 years of age or older for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia, caused by the following susceptible Gram-negative microorganisms: Acinetobacter baumannii complex, Escherichia coli, Enterobacter cloacae complex, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Serratia marcescens.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Fetroja and other antibacterial drugs, Fetroja should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.

Additional Information:

• Delivery Time: Within Week

Additional Information:

• Production Capacity: 36 months
• Delivery Time: within week

AstraZeneca’s Imjudo (tremelimumab) in combination with Imfinzi (durvalumab) has been approved in the US for the treatment of adult patients with unresectable hepatocellular carcinoma (HCC), the most common type of liver cancer. The novel dose and schedule of the combination, which includes a single dose of the anti-CTLA-4 antibody Imjudo 300mg added to the anti-PD-L1 antibody Imfinzi 1500mg followed by Imfinzi every four weeks, is called the STRIDE regimen (Single Tremelimumab Regular Interval Durvalumab).

The approval by the US Food and Drug Administration (FDA) was based on positive results from the HIMALAYA Phase III trial. In this trial, patients treated with the combination of Imjudo and Imfinzi experienced a 22% reduction in the risk of death versus sorafenib (based on a hazard ratio [HR] of 0.78, 95% confidence interval [CI] 0.66-0.92 p=0.0035).1 Results were also published in the New England Journal of Medicine Evidence showing that an estimated 31% of patients treated with the combination were still alive after three years, with 20% of patients treated with sorafenib still alive at the same duration of follow-up.2

Liver cancer is the third-leading cause of cancer death and the sixth most commonly diagnosed cancer worldwide.3,4 It is the fastest rising cause of cancer-related deaths in the US, with approximately 36,000 new diagnoses each year.5,6

Additional Information:

• Packaging Details: within a week

Additional Information:

• Production Capacity: 36 months
• Delivery Time: within week

Additional Information:

• Production Capacity: 36 months
• Delivery Time: within week

Additional Information:

• Packaging Details: within a week

Additional Information:

• Delivery Time: within week

Afinitor 10mg Tablet must be taken in a dose and duration as per the prescription. It can be taken with or without food but make sure to take it at about the same time every day. An overdose of this medicine may have serious side effects on the body.

The common side effects of this medicine include infection, fever, cough, fatigue, diarrhea, and upper respiratory infection. If any of the side effects persist or bother you, consult the doctor immediately. Inform the doctor immediately if you experience any allergic reactions (rash, shortness of breath, coughing, swelling, etc.). Always seek medical advice if you have increased thirst or increased frequency of urination, suffer from shortness of breath, cough or fever, or need to receive any vaccination after taking this medication.

Before taking this medicine, it is important to consult your doctor if you have any ongoing medication for any underlying disease. Pregnant and breastfeeding women must inform the doctor prior to the initiation of this treatment. During the treatment, your doctor may advise you for some laboratory tests to know the effects of the medicine in the body. It may affect male or female fertility, so consult the doctor if you are planning to have a child.

• Decreased appetite
• Increased glucose level in blood
• Pneumonitis
• Hypercholesterolemia (high cholesterol)
• Increased aspartate aminotransferase
• Decreased white blood cell count (lymphocytes)
• Lymphopenia
• Increased alanine aminotransferase
• Increased triglyceride level in blood
• Joint pain
• Pleural effusion
• Pulmonary edema

Certican 0.75mg Tablet must be taken in a dose and duration as per the prescription. It can be taken with or without food but make sure to take it at about the same time every day. An overdose of this medicine may have serious side effects on the body.

The common side effects of this medicine include infection, fever, cough, fatigue, diarrhea, and upper respiratory infection. If any of the side effects persist or bother you, consult the doctor immediately. Inform the doctor immediately if you experience any allergic reactions (rash, shortness of breath, coughing, swelling, etc.). Always seek medical advice if you have increased thirst or increased frequency of urination, suffer from shortness of breath, cough or fever, or need to receive any vaccination after taking this medication.

Before taking this medicine, it is important to consult your doctor if you have any ongoing medication for any underlying disease. Pregnant and breastfeeding women must inform the doctor prior to the initiation of this treatment. During the treatment, your doctor may advise you for some laboratory tests to know the effects of the medicine in the body. It may affect male or female fertility, so consult the doctor if you are planning to have a child.

• Decreased appetite
• Increased glucose level in blood
• Pneumonitis
• Hypercholesterolemia (high cholesterol)
• Increased aspartate aminotransferase
• Decreased white blood cell count (lymphocytes)
• Lymphopenia
• Increased alanine aminotransferase
• Increased triglyceride level in blood
• Joint pain
• Pleural effusion
• Pulmonary edema
• Rash
• Diarrhea
• Infection
• Breathlessness
• Stomatitis (Inflammation of the mouth)
• Fatigue
• Anemia (low number of red blood cells)
• Low blood platelets
• Decreased potassium level in blood
• Weight loss
• Taste change

Abcixirel 10mg Injection is administered under the supervision of a doctor. Your doctor will decide the dose and duration of the medicine for you. You should continue all your other medicines that are advised by the doctor for your long-term treatment even after this injection.
Use of this medicine may cause low blood platelets and increase your risk of bleeding. Let your doctor know immediately if you see pinpoint rash or blood in your vomits, urine, or stool. Your doctor will explain the benefits and risks associated with this medicine before it is administered.
This medicine is used with caution for some people. Thus, you must inform the doctor if you are suffering from any bleeding disorder, kidney or liver disease. Also, let your doctor know if you are pregnant or breastfeeding and about all the other medications that you are taking regularly.

Additional Information:

• Production Capacity: 36 months
• Delivery Time: within week